Pharmexa

Business Data, Corporate Office and Headquarter Address

About

Pharmexa is Biotechnology in Denmark that focus on T cell business. Founded in 1990. They cover business area such as manufacturer, cancer vaccine, T cell, epitope base immunotherapy, infectious disease.

Business Type

Biotechnology

Country

Denmark

Founded

1990
( 34 years old in 2024 )

Company Focus

T Cell

Website

-

Corporate Office and Headquarter Office address:

6, Kogle Alle
2970 Hørsholm
Denmark

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

manufacturercancer vaccineT cellepitope base immunotherapyinfectious disease

* We use standard office opening hours in near Pharmexa's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Pharmexa Frequently Asked Questions

What or who is Pharmexa?

Pharmexa is Biotechnology business from Denmark that founded in 1990 (34 years old in 2024), Pharmexa business is focusing on T Cell.

Where is Pharmexa headquarter and corporate office address?

Pharmexa headquarter office and corporate office address is located in 6, Kogle Alle 2970 Hørsholm Denmark.

Where is Pharmexa country origins?

Pharmexa was founded in Denmark.

What is T Cell business focus on?

In 2024, Pharmexa is currently focus on T cell sector.

T Cell Business Interest from Google Trend

Above is snippet of Google Trends for "T cell" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Pharmexa, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.